In agreement, our data from functional assays demonstrated that both OSA monocytes and monocytes from IH in vitro models exhibited high expression of HIF1α and VEGF, together inducing a cancer cell-promoting phenotype, whereas interfering assays reverted this phenotype. The gene discussed is HIF1A; the disease is isolated hemihyperplasia.